Rambus Inc. Form 10-Q Summary
Business context and reporting period
Rambus develops memory interface chips, semiconductor and security IP, and licenses patented technologies. The filing covers the quarter and six months ended June 30, 2021. Rambus operates as one reportable semiconductor segment. The financial statements are unaudited and 2020 comparable periods have been restated.
Financial performance and position
| Metric | Three months ended June 30, 2021 | Three months ended June 30, 2020 | Six months ended June 30, 2021 | Six months ended June 30, 2020 |
|---|---|---|---|---|
| Revenue | $84.9 million | $61.7 million | $155.2 million | $127.5 million |
| Gross profit | $68.0 million | $45.6 million | $121.0 million | $95.5 million |
| Gross margin | 80.1% | 73.8% | 77.9% | 74.9% |
| Operating income (loss) | $14.1 million | $(11.1) million | $10.6 million | $(20.6) million |
| Net income (loss) | $11.2 million | $(9.1) million | $8.6 million | $(15.7) million |
| Diluted EPS | $0.10 | $(0.08) | $0.07 | $(0.14) |
- Revenue mix: Second-quarter product revenue was $31.2 million, royalties were $41.9 million, and contract and other revenue was $11.8 million. Royalties represented 49.4% of quarterly revenue and 45.6% of year-to-date revenue.
- Operating expenses: Quarterly operating expenses were $53.9 million, down from $56.7 million; year-to-date expenses were $110.4 million, down from $116.0 million. Research and development decreased, while sales, general and administrative expense increased modestly.
- Cash flow: Six-month operating cash flow was $91.1 million versus $99.3 million in the prior-year period. Investing activities provided $96.4 million, primarily from marketable-security maturities and sales. Financing activities used $111.5 million, principally for share repurchases.
- Liquidity: Cash, cash equivalents and marketable securities totaled $477.1 million at June 30, 2021, including $204.7 million of cash and $272.4 million of marketable securities. Management expects existing liquidity and operating cash flow to meet cash needs for at least the next 12 months.
- Debt: The carrying value of the 1.375% convertible senior notes due 2023 was $159.8 million, with $172.5 million principal outstanding and scheduled maturity in February 2023. The notes had a fair value of $227.8 million at June 30, 2021.
- Capital returns: Rambus paid $100.0 million under a 2021 accelerated share repurchase program and retired approximately 3.9 million shares initially. Approximately 13.4 million shares remained authorized for repurchase at quarter-end.
Material changes versus the prior comparable period
- Quarterly revenue increased 37.5%, driven primarily by a 123.6% increase in royalty revenue associated with licensing renewals and timing. Six-month revenue increased 21.8%.
- Product revenue declined 1.7% in the quarter and 0.8% year to date, primarily because of lower memory interface chip sales. Management nevertheless expects product revenue to increase for full-year 2021.
- Gross margin expanded to 80.1% quarterly and 77.9% year to date, reflecting the higher royalty mix.
- The company moved from operating and net losses in the 2020 comparable periods to operating and net income in 2021.
- The 2020 restructuring plan, involving an approximately 70-employee reduction, was completed in the second quarter of 2021. Year-to-date restructuring charges were $0.4 million.
- Rambus restated prior-period results for revenue-recognition errors involving a single customer licensing agreement and corrected an immaterial classification error that moved $7.2 million from cash equivalents to marketable securities at December 31, 2020.
Guidance, outlook, risks and unusual items
- Management cited continued demand for memory interface chips, Silicon IP design wins, and stability in royalties supported by recent license renewals, including renewals or extensions with Qualcomm, Kioxia and Western Digital.
- Management expects product revenue to increase in 2021, research and development expenses to increase as technology investments continue, and sales, general and administrative expenses to remain relatively flat. No clear full-year numeric revenue or earnings guidance is provided in the filing text.
- Rambus announced a $100 million accelerated share repurchase program and announced acquisitions of AnalogX and PLDA. AnalogX was acquired on July 2, 2021 for approximately $47.7 million in cash. The PLDA transaction, involving approximately $60 million of cash, 0.3 million shares and potential earn-out shares, was expected to close in the third quarter of 2021.
- Revenue is concentrated: the top five customers represented approximately 55% of second-quarter revenue and 56% of six-month revenue. Licensing revenue can fluctuate materially based on renewals, customer shipment volumes, pricing and contract terms.
- Management identified potential near-term supply constraints affecting memory interface chips. COVID-19, semiconductor supply-chain disruption, customer concentration, international operations, technology competition, cybersecurity, intellectual-property disputes and changing tax laws remain material risks.
- The company reported a material weakness in internal control over financial reporting and ineffective disclosure controls as of June 30, 2021, relating to accounting for patent and technology licensing arrangements with unusual contract terms. Remediation had begun but was not yet complete.
- Unrecognized tax benefits totaled approximately $144.7 million, including amounts related to potential South Korean withholding-tax refunds. The ultimate outcome and timing cannot reasonably be estimated.
- The filing states that no material legal proceedings were pending, although ordinary-course claims and intellectual-property matters could still create costs or disruption.
Important facts for investors to verify
- Whether royalty revenue and recent license renewals are sustainable or reflect timing-related, non-recurring increases.
- Whether memory interface chip sales grow as management expects amid disclosed supply constraints and semiconductor cyclicality.
- The status and effectiveness of remediation for the material internal-control weakness, including any further restatements.
- The February 2023 convertible-note maturity and the company’s planned funding source or refinancing strategy.
- The final share count and settlement economics of the 2021 accelerated share repurchase program.
- The closing, purchase accounting and integration results for PLDA and AnalogX, including potential dilution and acquisition-related costs.
- The recoverability and timing of the $117.5 million South Korean withholding-tax refund-related asset and other uncertain tax positions.